Skip to main content
S

SLEEMON HEALTHY SLEEP TECHNOLOGY CO., LTD. — Investor Relations & Filings

Ticker · 603008 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 1,677 across all filing types
Latest filing 2026-04-24 Annual Report
Country CN China
Listing Shanghai Stock Exchange 603008

About SLEEMON HEALTHY SLEEP TECHNOLOGY CO., LTD.

SLEEMON HEALTHY SLEEP TECHNOLOGY CO., LTD. focuses on the research, development, and production of comprehensive sleep solutions. The company’s primary product range includes spring mattresses, latex mattresses, smart sleep systems, and upholstered furniture. By integrating ergonomic design with advanced material science, the firm develops products aimed at enhancing sleep health and spinal support. Its operations encompass the entire value chain, from design and manufacturing to global distribution. Sleemon serves a diverse clientele, including individual consumers and large-scale hospitality providers, offering both standardized and bespoke bedding products. The company distinguishes itself through its commitment to technological innovation in sleep science, utilizing automated manufacturing and smart monitoring features to provide data-driven sleep improvements.

Recent filings

Filing Released Lang Actions
喜临门健康睡眠科技股份公司2025年年度报告摘要
Annual Report Classification · 1% confidence The document is titled '喜临门健康睡眠科技股份公司2025年年度报告摘要' (Sleemon Health Sleep Technology Co., Ltd. 2025 Annual Report Summary). It contains key financial data, business descriptions, and shareholder information for the fiscal year 2025. Although it is an 'Annual Report Summary' (摘要), it contains substantive financial statements and analysis, which aligns with the definition of an Annual Report (10-K) in the context of financial reporting standards for listed companies. FY 2025
2026-04-24 Chinese
关于对喜临门健康睡眠科技股份公司2025年度财务报表发表非标准审计意见的专项说明
Audit Report / Information Classification · 1% confidence The document is a standalone audit-related report by the external auditor (Tianjian) providing a special explanatory note (“专项说明”) on the issuance of a non-standard (qualified) audit opinion on the company’s 2025 annual financial statements, detailing audit scope, basis, and specific matters. This falls under Audit Report / Information (Code: AR), not a full annual report or other filing type.
2026-04-24 Chinese
喜临门健康睡眠科技股份公司2025年年度内部控制审计报告
Audit Report / Information Classification · 1% confidence The document is an internal control audit report (“内部控制审计报告”) issued by a licensed accounting firm, containing the auditor’s opinion on the effectiveness of the company’s internal controls over financial reporting, details of major deficiencies, and attached professional credentials. It is a standalone audit report (not part of an annual or interim report), matching the definition of Audit Report / Information (Code: AR).
2026-04-24 Chinese
喜临门健康睡眠科技股份公司关于2025年度利润分配预案的公告
Notice of Dividend Amount Classification · 1% confidence The document is an official announcement by the company’s board regarding its 2025 profit distribution plan, detailing cash dividend decisions, share repurchase/annulment figures, and procedures for shareholder approval. This type of notice announcing dividend amounts and related profit distribution details corresponds to a Notice of Dividend Amount (DIV).
2026-04-24 Chinese
喜临门健康睡眠科技股份关于公司股票可能被实施退市风险警示的风险提示性公告
Delisting Announcement Classification · 1% confidence The document is a formal risk warning announcement under Shanghai Stock Exchange listing rules, advising investors that the company’s stock may be subject to a delisting risk warning (转为ST) and will be halted and risk-flagged due to a negative internal control audit. This is not an earnings release or management change, but specifically pertains to delisting risk under exchange rules. Therefore, it best fits the Delisting Announcement category (DLST).
2026-04-24 Chinese
喜临门健康睡眠科技股份公司关于2025年度计提资产减值准备的公告
Regulatory Filings Classification · 1% confidence The document is a standalone corporate announcement (公告) detailing the board-approved 2025 asset impairment provisions for a Shanghai-listed company. It includes specific impairment amounts for credit losses, inventory, fixed assets, and goodwill, and describes the decision process. It is not an annual or interim report, earnings release, director transaction, or other specialized filing. It is a general regulatory announcement of a one-off accounting event and does not fit any other specific category, so it is best classified under Regulatory Filings (RNS).
2026-04-24 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.